PAVmed Inc. APIC, Share-based Payment Arrangement, Increase for Cost Recognition
PAVmed Inc. (PAVM) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $909.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Shareholders' Equity › APIC, Share-Based Payment Arrangement, Increase for Cost Recognition
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-08-13
- PAVmed Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-06-30 was $909.00K, a 486.45% increase year-over-year.
- PAVmed Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-03-31 was $174.00K, a 27215.54% increase year-over-year.
- PAVmed Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-06-30 was $155.00K, a 85.99% decline year-over-year.
- PAVmed Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-03-31 was $637.00, a 99.91% decline year-over-year.
- PAVmed Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2025 was $1.39M, a 48.08% decline from fiscal 2024.
- PAVmed Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2024 was $2.68M, a 53.47% decline from fiscal 2023.
- PAVmed Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2023 was $5.76M, a 58.42% decline from fiscal 2022.
- PAVmed Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2022 was $13.86M, a 51.73% increase from fiscal 2021.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $909.00K 10-Q · filed 2026-08-13 | $1.08M 10-Q · filed 2026-08-13 | |||
| 2026-03-31 | $174.00K 10-Q · filed 2026-05-14 | ||||
| 2025-12-31 | $1.39M 10-K · filed 2026-03-27 | ||||
| 2025-06-30 | $155.00K 10-Q · filed 2026-08-13 | $792.00K 10-Q · filed 2026-08-13 | $65.64K derived: sum of 3 quarters · filed 2026-08-13 | $986.64K derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-03-31 | $637.00 10-Q · filed 2026-05-14 | -$89.36K derived: sum of 2 quarters · filed 2026-05-14 | $831.64K derived: sum of 3 quarters · filed 2026-05-14 | $1.94M derived: sum of 4 quarters · filed 2026-05-14 | |
| 2024-12-31 | -$90.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $831.00K derived: sum of 2 quarters · filed 2026-03-27 | $1.94M derived: sum of 3 quarters · filed 2026-03-27 | $2.68M 10-K · filed 2026-03-27 | $2.77M 10-K · filed 2025-03-24 |
| 2024-09-30 | $921.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $2.03M derived: sum of 2 quarters · filed 2024-11-14 | $2.77M 10-Q · filed 2024-11-14 | $3.52M derived: sum of 4 quarters · filed 2025-03-24 | |
| 2024-06-30 | $1.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | $1.85M 10-Q · filed 2024-08-12 | $2.60M derived: sum of 3 quarters · filed 2025-03-24 | $3.63M derived: sum of 4 quarters · filed 2025-03-24 | |
| 2024-03-31 | $744.00K 10-Q · filed 2024-05-13 | $1.49M derived: sum of 2 quarters · filed 2025-03-24 | $2.52M derived: sum of 3 quarters · filed 2025-03-24 | $3.69M derived: sum of 4 quarters · filed 2025-03-24 | |
| 2023-12-31 | $748.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | $1.78M derived: sum of 2 quarters · filed 2025-03-24 | $2.94M derived: sum of 3 quarters · filed 2025-03-24 | $5.76M 10-K · filed 2025-03-24 | |
| 2023-09-30 | $1.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $2.20M derived: sum of 2 quarters · filed 2023-11-13 | $5.01M 10-Q · filed 2023-11-13 | $8.50M derived: sum of 4 quarters · filed 2024-03-25 | |
| 2023-06-30 | $1.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $3.98M 10-Q · filed 2023-08-14 | $7.47M derived: sum of 3 quarters · filed 2024-03-25 | ||
| 2023-03-31 | $2.82M 10-Q · filed 2023-05-15 | $6.30M derived: sum of 2 quarters · filed 2024-03-25 | |||
| 2022-12-31 | $3.49M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | $13.86M 10-K · filed 2024-03-25 | |||
| 2022-09-30 | $10.37M 10-Q · filed 2022-11-14 | ||||
| 2021-12-31 | $9.13M 10-K · filed 2023-03-14 | ||||
| 2020-06-30 | $513.00K 10-Q · filed 2020-08-14 | $840.00K 10-Q · filed 2020-08-14 | |||
| 2020-03-31 | $328.00K 10-Q · filed 2020-05-28 | ||||
| 2019-12-31 | $1.40M 10-K · filed 2020-04-14 | ||||
| 2019-06-30 | $356.00K 10-Q · filed 2020-08-14 | $706.00K 10-Q · filed 2020-08-14 | |||
| 2019-03-31 | $350.00K 10-Q · filed 2020-05-28 | ||||
| 2018-12-31 | $1.18M 10-K · filed 2020-04-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| InspireMD, Inc. (NSPR) | $0.033B | ||
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| ACCURAY INC (ARAY) | United States | $0.027B | -0.63 |
| HeartBeam, Inc. (BEAT) | United States | $0.022B | -2.08 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| RETRACTABLE TECHNOLOGIES INC (RVP) | United States | $0.021B | -6.44 |
| FEMASYS INC (FEMY) | United States | $0.020B | -1.07 |
| Modular Medical, Inc. (MODD) | United States | $0.018B | -0.88 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |